½²×ù±àºÅ£ºjz-yjsb-2019-y077
½²×ùÎÊÌ⣺Cyclic nucleotide phosphodiesterases and its application
Ö÷ ½² ÈË£º¿ÂºâÃ÷ The University of North Carolina at Chapel Hill
½²×ùʱ¼ä£º2019Äê12ÔÂ06ÈÕ£¨ÐÇÆÚÎ壩ÏÂÖç16:10
½²×ùËùÔÚ£º¸·³É·Î÷Ð£Çø½ÌÈýÂ¥348ÊÒ
¼ÓÈ빤¾ß£ºÇṤ¿ÆÑ§ÊÖÒÕѧԺȫÌåʦÉú£¬È«Ð£¶Ô½²×ù¸ÐÐËȤµÄʦÉú
Ö÷Àíµ¥Î»£ºÑо¿ÉúÔº
³Ð°ìµ¥Î»£ºÇṤ¿ÆÑ§ÊÖÒÕѧԺ
Ö÷½²È˼ò½é£º
¿ÂºâÃ÷½ÌÊÚ£¬¹þ·ð´óѧÉúÎïÎïÀíѧ²©Ê¿£¬ÃÀ¹ú±±¿¨ÂÞÀ´ÄÉ´óѧ½ÌÌÃɽ·ÖУҽѧԺµÄÖÕÉí½ÌÊÚ£¬ÃÀ¹úNIHÊ×ϯ¿ÆÑ§¼Ò£¬Ê¦´Óŵ±´¶û»¯Ñ§½±»ñµÃÕßWilliam N. Lipscomb½ÌÊÚ¡£¿Â½ÌÊÚÔڽṹÉúÎïѧÑо¿·½ÃæÈ¡µÃÁËÌìÏÂ×ÅÃûµÄЧ¹û£¬ÒѾ½â³öÁËPDEµÈ10ÀàÂѰ×Öʵľ§Ìå½á¹¹¡£ÔÚCell£¬Science£¬Nature Struct. Biol.£¬Proc Natl Acad Sci U S A£¬J Biol Chem£¬J Med Chem.£¬Development£¬Biochem. Pharmacol.£¬Biochem J., J. Mol. Biol.µÈ¹ú¼ÊÖøÃûѧÊõÆÚ¿¯ÉϽÒÏþÂÛÎÄ80ÓàÆª¡£ÊÇAmerican Crystallographic Association£¬American Association for the Advancement of Science ίԱ£¬J. Biological Sciences, Current Bioactive Compounds ±àί£¬ÒÔ¼°Proc. Natl. Acad. Sci., J. Mol. Biol.,J. Biol. Chem.£¬EMBO J.£¬Biochemistry£¬Structure£¬Protein: structure, function and genetics£¬Nature Structural BiologyµÈ¶¥¼¶ÆÚ¿¯µÄÉó¸åÈË¡£
Ö÷½²ÄÚÈÝ£º
Cyclic nucleotide phosphodiesterases (PDEs) catalyse the hydrolysis of cyclic AMP and cyclic GMP, thereby regulating the intracellular concentrations of these cyclic nucleotides, their signalling pathways and, consequently, myriad biological responses in health and disease. PDE inhibitors are used clinically for treating the pathophysiological dysregulation of cyclic nucleotide signalling inerectile dysfunction, pulmonary hypertension, acute refractory cardiac failure, intermittent claudication and chronic obstructive pulmonary disease.